1. Home
  2. TENX vs ISSC Comparison

TENX vs ISSC Comparison

Compare TENX & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$13.64

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Logo Innovative Solutions and Support Inc.

ISSC

Innovative Solutions and Support Inc.

HOLD

Current Price

$16.34

Market Cap

346.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
ISSC
Founded
1967
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
346.6M
IPO Year
2001
2000

Fundamental Metrics

Financial Performance
Metric
TENX
ISSC
Price
$13.64
$16.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$29.67
$18.25
AVG Volume (30 Days)
898.1K
374.9K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
120.00
EPS
N/A
0.41
Revenue
N/A
N/A
Revenue This Year
N/A
$7.95
Revenue Next Year
N/A
$6.82
P/E Ratio
N/A
$39.98
Revenue Growth
N/A
N/A
52 Week Low
$5.67
$8.13
52 Week High
$18.38
$30.98

Technical Indicators

Market Signals
Indicator
TENX
ISSC
Relative Strength Index (RSI) 67.28 41.82
Support Level $13.16 $15.07
Resistance Level $14.15 $19.92
Average True Range (ATR) 0.72 1.07
MACD 0.30 0.02
Stochastic Oscillator 99.40 11.35

Price Performance

Historical Comparison
TENX
ISSC

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

Share on Social Networks: